If you need more lookups,
subscriptions start at $34 USD/month.
Mark Lundquist Location
New York, NY, US
Mark Lundquist Work
Head of Late Validation @ (September 2024 - Present)
Director, Head of Biology and Pharmacology @ (June 2024 - October 2024)
Associate Director of Biology @ (August 2022 - June 2024)
Senior Scientist @ (November 2018 - July 2022)
Instructor, Meyer Cancer Center @ (June 2018 - October 2018)
Postdoctoral Researcher, Meyer Cancer Center (Cantley Lab) @ (June 2012 - May 2018)
PhD Candidate, Dept. of Pharmacology (Jaffrey Lab) @ (January 2005 - May 2012)
Risk Analyst @ (August 2003 - May 2005)
Mark Lundquist Education
University of Pennsylvania
BSE (Chemical Engineering)
2021-2023
Columbia Business School
MBA
2021-2023
Weill Cornell Graduate School of Medical Sciences
PhD (Pharmacology)
2012
The Johns Hopkins University
Masters (Biotechnology)
2005
Mark Lundquist Summary
Mark Lundquist, based in New York, NY, US, is currently a Head of Late Validation at Ochre Bio. Mark Lundquist brings experience from previous roles at Alphina Therapeutics, Kadmon, a Sanofi Company and Weill Cornell Medicine. Mark Lundquist holds a 2021 - 2023 BSE in Chemical Engineering @ University of Pennsylvania. Mark Lundquist has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Lundquist?
Find contact details for 700 million professionals.